RE:PharmagradeThis is a valid observation and the pivot to 'pharma' is one that LABs made early enough.
But for me, this isn't whether or not people understand the pivot, or even if people understand the massive potential; it's whether LABs can survive and reward current shareholders while the cannabis/pharma market starts to build. LABs clearly doesn't have 3-5yrs to wait for FDA approval on in-flight studies and we as shareholders can't absorb more dilution or a dreaded RS without taking it even worse on the chin.
Nothing would make me happier than an announcement with a NA big....
Solid1 wrote: Note that Medipharm Labs is no longer a pure CBD oil company. They have all the licenses, CD license, DEL license and since October they have the CD-Sale license.
the market will probably play dumb for a while until it becomes clear that Labs is a pharmaceutical company... and all the studies that have come out lately show once again that cannabis will find its place in medicine.